Voro is developing a therapeutics platform of tumor-activated multi-specific antibodies (PrimeBody) to unleash the cancer immunotherapy potential of myeloid cells.
Company Details
- Employees
- 7
- Address
- 3210 Merryfield Row, San Diego,california 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vorotx.com
- Keywords
- masking, Myeloid cells, Cancer immunotherapy, Tumor-activated pro-biologics, Multi-specific antibodies.
- HQ
- San Diego, California
Voro Therapeutics Questions
Voro Therapeutics's website is http://www.vorotx.com
Voro Therapeutics's LinkedIn profile is https://www.linkedin.com/company/vorotx
Voro Therapeutics has
7 employees.
View email and phone details for 7
employees at Voro Therapeutics.
Voro Therapeutics's industry is
Biotechnology Research
Voro Therapeutics's top competitors are
Verseau Therapeutics,
Reactosome,
Orbits Oncology,
Ihp Therapeutics,
Eximius Diagnostics Corporation,
Cpg Diagnostics, Inc.,
Olfera,
Alloy Therapeutics, Inc.,
Tippingpoint Biosciences,
Sift Biosciences.
Voro Therapeutics's categories are Biotechnology Research
